Luminex logo

LMNX - Luminex News Story

$32.95 0.7  2.1%

Last Trade - 09/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £1.14bn
Enterprise Value £1.06bn
Revenue £304.5m
Position in Universe 2442nd / 6827

BRIEF-Luminex Receives FDA Emergency Use Authorization For Aries Sars-Cov-2 Assay To Detect Virus Responsible For Covid-19 Disease

Mon 6th April, 2020 12:36pm
April 6 (Reuters) - Luminex Corp  LMNX.O :
    * LUMINEX RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR
ARIES®
SARS-COV-2 ASSAY TO DETECT VIRUS RESPONSIBLE FOR COVID-19
DISEASE
    * LUMINEX CORP - NXTAG COV EXTENDED PANEL AND ARIES
SARS-COV-2
ASSAY HAVE EACH BEEN FUNDED WITH $642,450 OF FEDERAL FUNDS
    * LUMINEX - FINANCED REMAINING $1.1 MILLION OF NXTAG COV
EXTENDED
PANEL AND ARIES SARS-COV-2 ASSAY

Source text for Eikon:  ID:nPn7zQ6fXa 
Further company coverage:  LMNX.O 

 (Reuters.Briefs@thomsonreuters.com)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.